Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

290
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
290
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

2.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.7K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Specialized Care Centers and Settings-II01:30

Specialized Care Centers and Settings-II

736
Rural Health Centers
Rural health centers are specialized care facilities in remote locations with very few medical personnel. The primary care providers who run the centers are mostly Registered Nurse Practitioners. Here, emergency treatment is provided to critically ill or injured patients before they are transferred to the closest hospital. Fortunately, due to advancement in technology, many rural healthcare facilities and professionals have easy access to diagnostic and treatment...
736
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

557
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
557
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

274
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
274

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human versus analogue insulin for children and young adults with type 1 diabetes in low-resource settings (HumAn-1): a multicentre, open-label, randomised controlled trial.

The lancet. Diabetes & endocrinology·2026
Same author

Diagnosing established and acute HIV in the context of facility-based HIV testing services in rural Eswatini: a cross-sectional study.

Sexually transmitted infections·2026
Same author

Patient experiences and preferences for advanced HIV disease testing services: a qualitative study in Beira, Mozambique.

AIDS care·2026
Same author

Healthcare Professionals' Experience with Routine Mental Health Screening in Pediatric Diabetes Care: Findings from a Global Survey.

Hormone research in paediatrics·2026
Same author

Analogue insulin, GLP-1, and the WHO Model Essential Medicines List.

The lancet. Diabetes & endocrinology·2026
Same author

War in Lebanon: the hidden health crisis beyond the frontlines.

BMJ (Clinical research ed.)·2026

Related Experiment Video

Updated: Jul 12, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.9K

Diabetes Care in Humanitarian Settings.

Sylvia Kehlenbrink1, Kiran Jobanputra2, Amulya Reddy2

  • 1Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, 221 Longwood Avenue RFB-2, Boston, MA 02115, USA.

Endocrinology and Metabolism Clinics of North America
|October 21, 2023
PubMed
Summary

Diabetes care is often missing in humanitarian health programs, despite its growing prevalence and risks during crises. Addressing systemic barriers is crucial for improving health outcomes for affected populations.

Keywords:
DiabetesHealth equityHumanitarian crisesHumanitarian setting

More Related Videos

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
08:13

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT

Published on: January 7, 2018

68.6K
Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
05:06

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise

Published on: July 14, 2023

1.7K

Related Experiment Videos

Last Updated: Jul 12, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.9K
Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
08:13

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT

Published on: January 7, 2018

68.6K
Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
05:06

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise

Published on: July 14, 2023

1.7K

Area of Science:

  • Global Health
  • Public Health
  • Endocrinology

Background:

  • Diabetes prevalence is rising globally, particularly in vulnerable populations.
  • Individuals with diabetes face increased health risks during humanitarian crises.
  • Current humanitarian health interventions frequently exclude essential diabetes care.

Purpose of the Study:

  • To identify key factors hindering diabetes care integration in humanitarian settings.
  • To explore challenges in providing diabetes services during crises.
  • To propose interventions for equitable diabetes management in crisis-affected populations.

Main Methods:

  • Analysis of systemic barriers to diabetes care in humanitarian programs.
  • Examination of evolving humanitarian health paradigms.
  • Review of service provision complexities, social/cultural factors, and financing issues.

Main Results:

  • Four primary factors impede diabetes care inclusion: evolving health paradigms, service provision complexities, socio-cultural challenges, and inadequate financing.
  • These factors contribute to significant inequities in care for people with diabetes in crisis settings.
  • Lack of dedicated funding and complex logistical challenges are major obstacles.

Conclusions:

  • Diabetes care must be systematically integrated into humanitarian health interventions.
  • Addressing the identified barriers requires multi-faceted strategies involving policy, practice, and funding.
  • Improving diabetes care is essential for mitigating poor health outcomes in crisis-affected populations.